Background: SARS-CoV-2 infection poses a serious challenge for patients with rheumatic autoimmune systemic diseases (ASD), characterized by marked immune-system dysregulation and frequent visceral organ involvement. Objectives: To evaluate the impact of Covid-19 pandemic in a large series of Italian patients with ASD. Methods: Our multicenter telephone survey (8-week period, March-April 2020) included a large series of 2,994 patients (584 M, 2,410 F, mean age 58.9±13.4SD years) with ASD followed at 34 tertiary referral centers of 14 regions of northern, central, and southern Italian macro areas, characterized by different prevalence of SARS-CoV-2 infection. According to currently used criteria, Covid-19 was classified as definite Covid-19 (signs or symptoms of Covid-19 confirmed by positive oral/nasopharyngeal swabs at PCR testing) or highly suspected Covid-19 (signs or symptoms highly …

POS1246 COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY / Ferri, C; Giuggioli, D; Raimondo, V; Dagna, L; Riccieri, V; Zanatta, E; Guiducci, S; Tavoni, A; Foti, R; Cuomo, G; De Angelis, R; Cozzi, F; Murdaca, G; Cavazzana, I; Romeo, N; Codullo, V; Ingegnoli, F; Pellegrini, R; Varcasia, G; Della Rossa, A; De Santis, M; Abignano, G; Colaci, M; Caminiti, M; L’Andolina, M; Lubrano, E; Spinella, A; Lumetti, F; De Luca, G; Bellando Randone, S; Visalli, E; Bilia, S; Masini, F; Pellegrino, G; Pigatto, E; Generali, E; Franceschini, F; Pagano Mariano, G; Barsotti, S; Pettiti, G; Zanframundo, G; Brittelli, R; Aiello, V; Scorpiniti, D; Ferrari, T; Caminiti, R; Campochiaro, C; Gigliotti, P; Cecchetti, R; Olivo, D; Ursini, F; Brusi, V; Meliconi, R; Caso, F; Scarpa, R; D’Angelo, S; Iannone, F; Matucci-Cerinic, M; Doria, A; Miccoli, M; Paparo, Sr; Ragusa, F; Elia, G; Ferrari, Sm; Fallahi, P; Antonelli, A. - In: ANNALS OF THE RHEUMATIC DISEASES. THE EULAR JOURNAL. - ISSN 1792-328X. - 80:(2021), pp. 906-907. (Intervento presentato al convegno EULAR 2021 tenutosi a on line nel 2021).

POS1246 COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY

C Ferri;D Giuggioli;
2021

Abstract

Background: SARS-CoV-2 infection poses a serious challenge for patients with rheumatic autoimmune systemic diseases (ASD), characterized by marked immune-system dysregulation and frequent visceral organ involvement. Objectives: To evaluate the impact of Covid-19 pandemic in a large series of Italian patients with ASD. Methods: Our multicenter telephone survey (8-week period, March-April 2020) included a large series of 2,994 patients (584 M, 2,410 F, mean age 58.9±13.4SD years) with ASD followed at 34 tertiary referral centers of 14 regions of northern, central, and southern Italian macro areas, characterized by different prevalence of SARS-CoV-2 infection. According to currently used criteria, Covid-19 was classified as definite Covid-19 (signs or symptoms of Covid-19 confirmed by positive oral/nasopharyngeal swabs at PCR testing) or highly suspected Covid-19 (signs or symptoms highly …
2021
EULAR 2021
on line
2021
Ferri, C; Giuggioli, D; Raimondo, V; Dagna, L; Riccieri, V; Zanatta, E; Guiducci, S; Tavoni, A; Foti, R; Cuomo, G; De Angelis, R; Cozzi, F; Murdaca, G; Cavazzana, I; Romeo, N; Codullo, V; Ingegnoli, F; Pellegrini, R; Varcasia, G; Della Rossa, A; De Santis, M; Abignano, G; Colaci, M; Caminiti, M; L’Andolina, M; Lubrano, E; Spinella, A; Lumetti, F; De Luca, G; Bellando Randone, S; Visalli, E; Bilia, S; Masini, F; Pellegrino, G; Pigatto, E; Generali, E; Franceschini, F; Pagano Mariano, G; Barsotti, S; Pettiti, G; Zanframundo, G; Brittelli, R; Aiello, V; Scorpiniti, D; Ferrari, T; Caminiti, R; Campochiaro, C; Gigliotti, P; Cecchetti, R; Olivo, D; Ursini, F; Brusi, V; Meliconi, R; Caso, F; Scarpa, R; D’Angelo, S; Iannone, F; Matucci-Cerinic, M; Doria, A; Miccoli, M; Paparo, Sr; Ragusa, F; Elia, G; Ferrari, Sm; Fallahi, P; Antonelli, A
File in questo prodotto:
File Dimensione Formato  
Poster EULAR COVID 19 .pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 204.39 kB
Formato Adobe PDF
204.39 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1253653
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact